TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
89.98
+3.00 (3.45%)
At close: Sep 4, 2026, 4:00 PM EDT
89.88
-0.10 (-0.11%)
After-hours: Sep 4, 2026, 7:51 PM EDT

TransMedics Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
151.7190.2935.46-25.03-36.23-44.22
Depreciation & Amortization
34.0225.8919.768.183.481.82
Other Amortization
2.41.3----
Loss (Gain) From Sale of Assets
-0.080.02---
Asset Writedown & Restructuring Costs
---27.21--
Loss (Gain) From Sale of Investments
----0.491.36
Stock-Based Compensation
37.0936.8633.2219.7910.326.88
Other Operating Activities
-65.08-79.955.341.172.892.3
Change in Accounts Receivable
0.6213.95-34.31-33.82-21.680.84
Change in Inventory
-23.68-7.72-8.35-28.09-8.02-4.89
Change in Accounts Payable
3.12-0.02-1.46.96-3.275.09
Change in Unearned Revenue
1.561.14-0.20.08-0.01
Change in Other Net Operating Assets
4.1811.02-0.7410.526.211.96
Operating Cash Flow
145.93192.8448.8-13.03-45.82-28.86
Operating Cash Flow Growth
26.59%295.14%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-66.89-59.25-129.74-151.85-11.91-3.52
Cash Acquisitions
--0.44-14.89--
Sale (Purchase) of Intangibles
----27.21--
Investment in Securities
----66.4232.79
Investing Cash Flow
-66.89-59.25-129.3-193.9554.5129.27

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---46058.51-
Total Debt Issued
---46058.51-
Long-Term Debt Repaid
----52.07-36.05-
Total Debt Repaid
----52.07-36.05-
Net Debt Issued (Repaid)
---407.9322.46-
Issuance of Common Stock
11.791722.877.11145.471.39
Repurchase of Common Stock
-0.32-0.14----
Other Financing Activities
----14.62--
Financing Cash Flow
11.4716.8622.87400.42167.931.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.481.27-0.540.19-1.02-0.8
Net Cash Flow
90.04151.72-58.16193.63175.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
79.04133.59-80.94-164.88-57.72-32.38
Free Cash Flow Growth
355.51%-----
Free Cash Flow Margin
11.82%22.06%-18.33%-68.24%-61.76%-107.01%
Free Cash Flow Per Share
2.063.29-2.30-5.07-1.95-1.17
Levered Free Cash Flow
44.594-102.77-192.83-45.96-15.66
Unlevered Free Cash Flow
57.77102.62-93.76-186.09-43.64-13.24

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
10.710.711.38.093.263.33
Change in Working Capital
-14.2118.38-45-44.35-26.763
SEC Filings: 10-K · 10-Q